Donohue JF - Search Results

1

Another Choice for Prevention of COPD Exacerbations.

Donohue JF. Donohue JF. N Engl J Med. 2016 Jun 9;374(23):2284-6. doi: 10.1056/NEJMe1604444. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181835 No abstract available.

2

Still looking for answers in COPD.

Donohue JF. Donohue JF. Lancet. 2005 Apr 30-May 6;365(9470):1518-20. doi: 10.1016/S0140-6736(05)66432-X. Lancet. 2005. PMID: 15866290 No abstract available.

3

Evaluation of the efficacy and safety of levalbuterol in subjects with COPD.

Donohue JF, Parsey MV, Andrews C, D'Urzo T, Sharma S, Schaefer K, Claus R, Baumgartner RA; Levalbuterol COPD Study Group. Donohue JF, et al. COPD. 2006 Aug;3(3):125-32. doi: 10.1080/15412550600829190. COPD. 2006. PMID: 17240614 Clinical Trial.

4

Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.

Ohar JA, Donohue JF. Ohar JA, et al. Among authors: donohue jf. Semin Respir Crit Care Med. 2010 Jun;31(3):321-33. doi: 10.1055/s-0030-1254072. Epub 2010 May 21. Semin Respir Crit Care Med. 2010. PMID: 20496301 Review.

5

Safety of indacaterol in the treatment of patients with COPD.

Donohue JF, Singh D, Kornmann O, Lawrence D, Lassen C, Kramer B. Donohue JF, et al. Int J Chron Obstruct Pulmon Dis. 2011;6:477-92. doi: 10.2147/COPD.S23816. Epub 2011 Sep 22. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 22003293 Free PMC article.

6

Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.

Donohue JF, Worsley S, Zhu CQ, Hardaker L, Church A. Donohue JF, et al. Respir Med. 2015 Jul;109(7):870-81. doi: 10.1016/j.rmed.2015.04.018. Epub 2015 May 8. Respir Med. 2015. PMID: 26006754 Free article. Clinical Trial.

7

Indacaterol vs tiotropium in COPD patients classified as GOLD A and B.

Mahler DA, Kerstjens HA, Donohue JF, Buhl R, Lawrence D, Altman P. Mahler DA, et al. Among authors: donohue jf. Respir Med. 2015 Aug;109(8):1031-9. doi: 10.1016/j.rmed.2015.05.012. Epub 2015 May 22. Respir Med. 2015. PMID: 26094050 Free article. Clinical Trial.

8

Low Doses of Long-Acting β-Agonists/Long-Acting Muscarinic Agents with Large Effects. The FLIGHT Study.

Donohue JF. Donohue JF. Am J Respir Crit Care Med. 2015 Nov 1;192(9):1028-30. doi: 10.1164/rccm.201507-1442ED. Am J Respir Crit Care Med. 2015. PMID: 26517413 No abstract available.

9

Response to Letter to the Editor: Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.

Donohue JF. Donohue JF. Respir Med. 2016 Jan;110:81. doi: 10.1016/j.rmed.2015.11.011. Epub 2015 Nov 27. Respir Med. 2016. PMID: 26689766 Free article. No abstract available.

10

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA.

Cohen JS, Miles MC, Donohue JF, Ohar JA. Cohen JS, et al. Among authors: donohue jf. Int J Chron Obstruct Pulmon Dis. 2016 Apr 15;11:785-97. doi: 10.2147/COPD.S54513. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27143870 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page